BridgeBio Pharma, Inc. (64) | Compensation Agreements (2)

Recent Contracts

Amended and Restated Director Compensation Policy (Filed With SEC on February 25, 2022)
Director Compensation Policy (Filed With SEC on March 3, 2020)